Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins

Comparison of Preferences Between OnabotulinumtoxinA (Botox) and IncobotulinumtoxinA (Xeomin) in the Treatment of Benign Essential Blepharospasm

(2013) Rao V. Chundury et al.   OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY

A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines

(2012) Marion Moers-Carpi et al.   Journal of Cosmetic and Laser Therapy

Five-year experience with incobotulinumtoxinA (Xeomin®): the first botulinum toxin drug free of complexing proteins

(2011) D. Dressler   EUROPEAN JOURNAL OF NEUROLOGY

Measuring the potency labelling of onabotulinumtoxinA (Botox®) and incobotulinumtoxinA (Xeomin®) in an LD50 assay

(2011) Dirk Dressler et al.   JOURNAL OF NEURAL TRANSMISSION

Xeomin is free from complexing proteins

(2009) Jürgen Frevert   TOXICON

Potency Evaluation of a Formulated Drug Product Containing 150-kd Botulinum Neurotoxin Type A

(2008) Terrence Hunt et al.   CLINICAL NEUROPHARMACOLOGY